Today: 14 May 2026
Browse Category

Earnings Reports 17 November 2025 - 18 November 2025

Baidu (BIDU) Q3 2025 Earnings: Revenue Falls 7% as AI Cloud and Robotaxis Power a Big EPS Beat

Baidu (BIDU) Q3 2025 Earnings: Revenue Falls 7% as AI Cloud and Robotaxis Power a Big EPS Beat

Baidu reported Q3 2025 revenue of RMB 31.2 billion, down 7% year over year but above analyst estimates. The company posted a net loss of RMB 11.2 billion, mainly due to a RMB 16.2 billion impairment. Non-GAAP net income reached RMB 3.8 billion, beating expectations. AI-powered business revenue surged over 50% to nearly RMB 10 billion, while online ad revenue fell 18%.
18 November 2025
··
Medtronic (MDT) Soars as Q2 FY26 Earnings Beat Expectations and 2026 Outlook Is Raised on Pulsed Field Ablation Strength

Medtronic Stock Jumps Above $100 After Q2 FY26 Beat and Raised Outlook on 18 November 2025

Medtronic shares jumped 4–5% to around $100–101 late Tuesday morning, hitting a three-year high after the company beat fiscal Q2 2026 earnings and revenue forecasts and raised its full-year outlook. Revenue rose 6.6% to $9.0 billion, with adjusted EPS of $1.36 topping analyst estimates. The rally pushed Medtronic’s market cap to about $129 billion. Demand for heart and diabetes devices drove the gains.
18 November 2025
··
Medtronic (MDT) Soars as Q2 FY26 Earnings Beat Expectations and 2026 Outlook Is Raised on Pulsed Field Ablation Strength

Medtronic (MDT) Soars as Q2 FY26 Earnings Beat Expectations and 2026 Outlook Is Raised on Pulsed Field Ablation Strength

Medtronic reported Q2 FY26 revenue of $8.96 billion, up 6.6% year over year, and non-GAAP EPS of $1.36, beating Wall Street estimates. Shares rose 4–5% intraday. Cardiac ablation revenue jumped 71% globally, with 128% growth in the U.S. The company raised its full-year outlook after its fourth straight quarter of beating consensus EPS.
18 November 2025
···
VOO Today: Vanguard S&P 500 ETF slips as Wall Street braces for Nvidia earnings and a heavy data slate — Nov. 18, 2025

VOO Today: Vanguard S&P 500 ETF slips as Wall Street braces for Nvidia earnings and a heavy data slate — Nov. 18, 2025

The Vanguard S&P 500 ETF (VOO) traded near $604.85, down about 1.2% intraday Tuesday, after a tech-led selloff pulled the S&P 500 lower by 0.9% on Monday. Traders are watching for Nvidia’s Q3 FY26 earnings Wednesday, with options signaling a possible sharp move. Fund flows into VOO remain strong, with about $6.6 billion in net inflows reported over five days.
18 November 2025
····
Stock Market Today (Nov. 18, 2025): Nasdaq slides as AI trade stumbles; Tesla, Palantir, SMCI pace tech losses ahead of Nvidia earnings; Disney ends YouTube TV blackout

Stock Market Today (Nov. 18, 2025): Nasdaq slides as AI trade stumbles; Tesla, Palantir, SMCI pace tech losses ahead of Nvidia earnings; Disney ends YouTube TV blackout

U.S. stocks fell for a fourth straight session Tuesday, with the Dow down nearly 500 points intraday and the Nasdaq off up to 1.5% as investors sold AI-linked shares and weighed fading odds of a December Fed rate cut. Tesla, Palantir, and Super Micro Computer posted notable declines. Nvidia’s earnings report Wednesday looms, with options markets bracing for a 7% swing. A Cloudflare outage briefly disrupted major tech services, adding to sector jitters.
18 November 2025
········
Stock Market Today, 18 November 2025: Dow Extends Slide as AI Bubble Fears Grow and Home Depot Earnings Rattle Wall Street

Stock Market Today, 18 November 2025: Dow Extends Slide as AI Bubble Fears Grow and Home Depot Earnings Rattle Wall Street

U.S. stocks fell Tuesday, with the Dow down nearly 1%, the S&P 500 off 0.5%, and the Nasdaq 100 slipping 0.9% by late morning. Renewed fears of an AI bubble ahead of Nvidia’s earnings and a weaker outlook from Home Depot fueled the decline. All three indexes hovered near one-month lows, extending Monday’s losses. Home Depot shares dropped over 3% after missing profit estimates.
18 November 2025
·····
Synovus Financial (SNV) Stock: Q3 Earnings Beat, Barclays Price Target Hike and Fresh Institutional Buying – November 18, 2025

Synovus Financial (SNV) Stock: Q3 Earnings Beat, Barclays Price Target Hike and Fresh Institutional Buying – November 18, 2025

Synovus Financial reported Q3 adjusted EPS of $1.46, beating estimates by $0.10, with revenue up 9% to about $612 million. Shares have risen 4.5% since October’s earnings release, trading near $44 as of mid-day November 18. Barclays raised its price target to $65, and new 13F filings show increased institutional ownership. Non-performing loans and charge-offs fell sharply in the quarter.
18 November 2025
·
Klarna Q3 2025 Earnings: 26% Revenue Jump and $6.5B Elliott Deal Put ‘Fair Financing’ at the Center of Its US Growth Story

Klarna Q3 2025 Earnings: 26% Revenue Jump and $6.5B Elliott Deal Put ‘Fair Financing’ at the Center of Its US Growth Story

Klarna reported Q3 2025 revenue of $903 million, up 26% year-on-year and above analyst estimates. The company posted a net loss of $95 million, reversing a profit from a year earlier. Klarna also announced a $6.5 billion loan-sale deal with Elliott Investment Management to expand its US “Fair Financing” product. Management expects Q4 revenue to surpass $1 billion.
18 November 2025
··
Home Depot Stock Pre-Market Report: Key Catalysts & Forecast for Nov. 3, 2025

Home Depot (HD) Stock Falls After Q3 2025 Earnings Miss and Profit Warning – What Investors Need to Know Today (November 18, 2025)

Home Depot shares fell 2–3% in premarket trading after third-quarter earnings missed estimates and management cut its full-year profit outlook. Net sales rose 2.8% to $41.4 billion, boosted by the GMS acquisition, but comparable sales increased just 0.2%. Adjusted EPS dropped to $3.74, below forecasts. Management now expects adjusted EPS to fall about 5% for fiscal 2025.
18 November 2025
··
NVIDIA 2025: Dominating the AI Boom – Company Overview, Key Segments, Competition, and Future Outlook

Nvidia Stock Today, November 17, 2025: NVDA Slips as Wall Street Braces for High-Stakes Q3 Earnings

Nvidia shares fell 1.3% to around $187.70 by early afternoon Monday, with volume topping 85 million ahead of its fiscal Q3 earnings due November 19. The stock traded between $185.0 and $192.3 as Wall Street indexes slipped and traders braced for a potential 7% post-earnings swing. Investors cited profit-taking and uncertainty in the AI sector.
17 November 2025
···
US Stock Market Today, November 17, 2025: Wall Street Wobbles as Nvidia Earnings and Jobs Data Loom

US Stock Market Today, November 17, 2025: Wall Street Wobbles as Nvidia Earnings and Jobs Data Loom

The Dow fell 0.2% to around 47,100 and the S&P 500 slipped 0.1% near 6,726 by late morning Monday, while the Nasdaq was flat near 22,890. Nvidia shares dropped 1–2% ahead of its earnings report this week. Alphabet hit record highs after a rare Warren Buffett investment. Traders remained cautious, with limited buying or selling.
17 November 2025
···
Elbit Systems (ESLT) Jumps on $2.3 Billion Contract Win as Q3 Earnings Loom – 17 November 2025 Update

Elbit Systems (ESLT) Jumps on $2.3 Billion Contract Win as Q3 Earnings Loom – 17 November 2025 Update

Elbit Systems announced a $2.3 billion international defense contract to be delivered over eight years, with the customer and systems undisclosed. The news sent ESLT shares sharply higher on both the Nasdaq and TASE. The deal was confirmed in a press release and SEC filing one day before Elbit’s Q3 2025 earnings report.
17 November 2025
···
ZIM Integrated Shipping (NYSE: ZIM) Jumps Toward $17 as Bulltick Boosts Stake Ahead of Q3 Earnings – November 17, 2025

ZIM Integrated Shipping (NYSE: ZIM) Jumps Toward $17 as Bulltick Boosts Stake Ahead of Q3 Earnings – November 17, 2025

ZIM shares jumped about 6% to $17 late morning Monday as traders positioned ahead of Thursday’s Q3 earnings report. Bulltick Wealth Management increased its stake by 33% to 88,000 shares. Options markets priced in an 11–12% move post-earnings, signaling volatility. Today is also the record date for ZIM’s December 19 shareholder meeting in Haifa.
17 November 2025
··
Sigma Lithium (SGML) Stock Soars in Premarket as Lithium Demand Hopes Collide With Q3 2025 Turnaround

Sigma Lithium (SGML) Stock Soars in Premarket as Lithium Demand Hopes Collide With Q3 2025 Turnaround

Sigma Lithium shares surged over 30% in premarket U.S. trading Monday, hitting as high as $8.20 on volume exceeding 12 million shares. The rally follows strong Q3 2025 results and a bullish lithium demand forecast from China’s Ganfeng Lithium. Sigma closed Friday at $6.06, up 2.7% on heavy volume. Lithium futures in Guangzhou jumped 9% after Ganfeng projected 30% demand growth in 2026.
17 November 2025
···
Dragonfly Energy (DFLI) Stock Pops as Canaccord Hikes Price Target to $2.25 After Big Q3 Earnings Beat

Dragonfly Energy (DFLI) Stock Pops as Canaccord Hikes Price Target to $2.25 After Big Q3 Earnings Beat

Dragonfly Energy shares rose 4.8% to $0.81 Monday after Canaccord Genuity raised its price target to $2.25 and reiterated a Buy rating, citing a stronger balance sheet. The move followed Q3 results showing a narrower loss of –$0.20 per share versus expectations for –$0.71, with revenue up 26% to $16 million and gross margin expanding to 29.7%.
17 November 2025
··
XPeng Stock (XPEV) Slides After Q3 2025 Earnings: Record Deliveries, Narrower Loss but Soft Q4 Guidance

XPeng Stock (XPEV) Slides After Q3 2025 Earnings: Record Deliveries, Narrower Loss but Soft Q4 Guidance

XPeng reported record Q3 2025 deliveries of 116,007 vehicles, up 149% year-on-year, with revenue doubling to RMB 20.38 billion and gross margin rising to 20.1%. Net loss narrowed to RMB 380 million, the smallest in five years. The company guided Q4 revenue below analyst expectations, citing fierce competition. Shares fell about 3% in pre-market trading.
17 November 2025
···
QUBT Stock Today, November 17, 2025: Neurawave Launch and Q3 Earnings Put Quantum Computing Inc. Back in the Spotlight

QUBT Stock Today, November 17, 2025: Neurawave Launch and Q3 Earnings Put Quantum Computing Inc. Back in the Spotlight

Quantum Computing Inc. (NASDAQ: QUBT) shares rose about 6% to $10.60 early afternoon November 17 after announcing its Neurawave photonic computing platform ahead of SuperCompute25. The stock spiked up to 21% premarket before paring gains. QUBT cited triple-digit Q3 revenue growth and a surprise swing to GAAP profitability. Shares remain down roughly 35–40% year-to-date.
17 November 2025
···
$100 B Bank Fraud Scandal Triggers Global Market Rout – DAX Sinks Below 24,000 Amid ‘Cockroach’ Fears

DAX Today: German Stock Market Edges Lower as Investors Wait for US Data and Nvidia Earnings (17 November 2025)

Germany’s DAX 40 slipped to around 23,750–23,800 points Monday, down 0.3–0.6% by late morning in Frankfurt as traders awaited key US economic data and Nvidia earnings. The index remains up about 19% for 2025 but sits below its October record high near 24,800. The STOXX 600 also edged lower. Volatility measures for the DAX hovered near 16%, below recent peaks.
17 November 2025
··
Nvidia Stock Today, November 17, 2025: NVDA Climbs as Wall Street Braces for Make‑or‑Break AI Earnings

Nvidia Stock Today, November 17, 2025: NVDA Climbs as Wall Street Braces for Make‑or‑Break AI Earnings

Nvidia shares rose about 1.7% to near $190 on November 17, 2025, ahead of Wednesday’s Q3 earnings report. Investors are watching for signs of continued AI demand, while high expectations call for revenue of $54.8–$54.9 billion and EPS growth over 50%. The stock’s market cap stands at roughly $4.6 trillion, with intraday trading between $180.40 and $191.06.
17 November 2025
···
1 … 220 221 222 223 224 … 247

Stock Market Today

  • Nurix Therapeutics Stock: Is Its Premium 23.3x Price-to-Sales Multiple Justified?
    May 14, 2026, 9:02 AM EDT. Nurix Therapeutics (NRIX) shares rose 1.38% to $16.18 amid mixed recent performance, down 10% year to date but up nearly 69% over one year. The stock trades at a high price-to-sales (P/S) multiple of 23.3x, well above the US biotech average of 9.7x. This premium reflects strong analyst revenue growth forecasts of 42.2% annually, outpacing the broader market. However, Nurix remains loss-making with $295 million in ongoing losses and a $1.65 billion market cap, making it vulnerable to clinical setbacks. Investors should weigh the high growth potential against risks in this early-stage biotech before assuming the premium valuation is sustainable.

Latest articles

Apple Backs Google in EU AI Fight as iPhone Rules Loom

Apple Backs Google in EU AI Fight as iPhone Rules Loom

14 May 2026
Apple warned the European Commission that proposed EU rules forcing Google’s Android to open core features to rival AI assistants could endanger privacy, security, and device performance. The Commission’s feedback period closed Wednesday, with a final decision expected by July 27. Apple argued the measures could set a precedent for its own platforms. Google also opposes the plan, calling it an “unwarranted intervention.”
Precigen Stock Jumps as Papzimeos Sales Change the Story for PGEN Investors

Precigen Stock Jumps as Papzimeos Sales Change the Story for PGEN Investors

14 May 2026
Precigen shares jumped 14.1% in early trading after first-quarter revenue reached $23.3 million, beating estimates, and net loss narrowed to $7.9 million from $54.2 million a year earlier. Papzimeos, its new RRP therapy, generated $21.6 million in net product revenue. The company ended March with $56.7 million in cash and expects current funds and Papzimeos sales to last through 2026.
POET Stock Jumps After $50 Million Lumilens AI Optics Order — The Bigger Test Comes Later

POET Stock Jumps After $50 Million Lumilens AI Optics Order — The Bigger Test Comes Later

14 May 2026
POET Technologies signed a supply and joint-development agreement with Lumilens, including a $50 million initial order for optical engines used in AI data-center networks. The companies said cumulative purchases could exceed $500 million over five years. POET shares rose 16% after the news. First engineering samples are expected in late 2026, with production targeted for 2027.
Go toTop